C12Y 304/24023
Matrilysin
Official title: Matrilysin (3.4.24.23)
C12Y304/24023 (Matrilysin) appears on 9 US grants and 15 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 15
- Assignees
- 13
- Inventors
- 32
- Latest grant
- 6 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 3 | 2 |
| 2017 | 0 | 2 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereof6 May 2025US 12,291,578 B2Yeda Research and Development Co. Ltd.
- Method for quantifying therapeutic antibodies3 Jan 2023US 11,543,416 B2Promise Proteomics
- Therapy25 May 2021US 11,013,786 B2SelectImmune Pharma AB
- Method for monomerizing matrix metalloproteinase 7 (MMP-7) aggregate15 Sep 2020US 10,774,321 B2KM Biologics Co., Ltd.
- Gelatinase inhibitors and prodrugs16 Jan 2018US 9,867,805 B2University of Notre Dame du Lac
- Diagnosis and treatment of pancreatic cancer26 Sep 2024US 2024/0319194 A1Sheba Impact Ltd.
- Modified Cell Targeting Tumor ECM and Cellular Therapy thereof19 Sep 2024US 2024/0307442 A1Innovative Cellular Therapeutics Holdings, Ltd.
- RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use24 Aug 2023US 2023/0265437 A1Arrowhead Pharmaceuticals, Inc.
- Anti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof7 Apr 2022US 2022/0106405 A1Yeda Research and Development Co. Ltd.
- Novel therapy19 Aug 2021US 2021/0252107 A1SelectImmune Pharma AB
Most cited
By later US patents
- Systems, compositions, and methods for transplantation and treating conditions14US 9,352,021 B2Cytonics Corporation · 2016
- Gelatinase inhibitors and prodrugs3US 8,937,151 B2University of Notre Dame du Lac · 2015
- Gelatinase inhibitors and prodrugs2US 9,321,754 B2University of Notre Dame du Lac · 2016
- Systems, compositions, and methods for transplantation and treating conditions1US 9,498,514 B2Cytonics Corporation · 2016
- Gelatinase inhibitors and prodrugs1US 9,867,805 B2University of Notre Dame du Lac · 2018